OXURION (EBR:OXUR) | Finanzwire

Basculer en Français

9472	Companies
185369	Keywords
117719	Articles
99261	Press releases

Home
Companies
OXURION

BRIEF

published on 12/01/2025 at 08:05, 3 days 21 hours ago

Oxurion secures major funding for cryptocurrency investments

Investment Strategy Convertible Bonds Funding Cryptocurrencies ATLAS Capital Markets
PRESS RELEASE

published on 12/01/2025 at 08:00, 3 days 21 hours ago

Oxurion secures a binding EUR 30 million financing facility dedicated to investments in digital and crypto assets
Oxurion NV secures €30 million financing via convertible bonds from Atlas Capital Markets to invest in digital assets like Bitcoin and Ethereum. The strategy aligns with the company's long-term investment policy

Convertible Bonds Bitcoin Digital Assets Finance Oxurion NV
BRIEF

published on 11/25/2025 at 18:05, 9 days 11 hours ago

Oxurion receives a transparency notification from Atlas Special Opportunities II LLC

Actions Transparency Health Oxurion Atlas Special Opportunities II LLC
PRESS RELEASE

published on 11/25/2025 at 18:00, 9 days 11 hours ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV received a transparency notification from Atlas Special Opportunities II, LLC indicating a change in share ownership. The company specializes in acquiring stakes in European pharmaceutical subcontractors

Transparency Notification Share Ownership Oxurion NV Belgian Transparency Legislation European Pharmaceutical Subcontractors
BRIEF

published on 11/20/2025 at 18:05, 14 days 11 hours ago

Oxurion receives a transparency notification from Atlas Special Opportunities II LLC

Digital Assets Transparency Notification Belgium Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 11/20/2025 at 18:00, 14 days 11 hours ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV receives transparency notification from Atlas Special Opportunities II, LLC indicating a decrease in shareholding percentage due to sale of voting securities

Transparency Notification Oxurion NV Voting Securities Atlas Special Opportunities II, LLC Shareholding Percentage
BRIEF

published on 11/03/2025 at 18:05, 1 month 1 day ago

Oxurion Concludes Preclinical Discussions, Focuses on Strategic Clinical Integration

Strategic Acquisition Oxurion Clinical Integration Pharmaceutical Subcontractors Preclinical Termination
PRESS RELEASE

published on 11/03/2025 at 18:00, 1 month 1 day ago

Oxurion ends discussions regarding previously announced preclinical transaction and continues integration of a strategic clinical partner
Oxurion NV terminates acquisition discussions but moves forward with clinical integration and consolidation strategy. Upholding financial discipline and commitment to high-value services

High-value Services Oxurion NV Consolidation Strategy Clinical Integration Acquisition Termination
BRIEF

published on 10/23/2025 at 18:05, 1 month 12 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC

Actions Transparency Notification Atlas Special Opportunities Oxurion Belgian Regulations
PRESS RELEASE

published on 10/23/2025 at 18:00, 1 month 12 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV received a transparency notification from Atlas Special Opportunities II, LLC regarding shareholding threshold crossing. The company specializes in acquiring stakes in European pharmaceutical subcontractors

Transparency Notification Shareholding Threshold Oxurion NV Belgian Transparency Legislation European Pharmaceutical Subcontractors

Accesswire

Published on 12/05/2025 at 02:35, 2 hours 49 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 2 hours 54 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 4 hours 24 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 19 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 6 hours 24 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 03:30, 1 hour 53 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 5 hours 33 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 8 hours 58 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 8 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 13 minutes ago

SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance

Les Echos

Published on 12/04/2025 at 18:00, 11 hours 24 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 11 hours 39 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 11 hours 39 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 23 minutes ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 11 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE